4.0
Aug 7, 2025
Recommend
CEO approval
Business Outlook
Pros
Overall good experience, left to pursue other opportunities as progression was limited but this is due to the nature of the Irish wing of the business and not due to management
Cons
Essentially a support function for more interesting international projects. Similar to pharma, Ireland runs most of the QA/QC programmes and isn’t as involved in the cutting edge/innovation side of the business